Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Merck
Medtronic
Express Scripts
Moodys

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

TECHNESCAN Drug Profile

See Plans and Pricing

« Back to Dashboard

Drug patent expirations by year for TECHNESCAN
Recent Litigation for TECHNESCAN

Identify potential future generic entrants

District Court Litigation
Case NameDate
Tripharma LLC v. First Fruits Business Ministry LLC2012-03-14

See all TECHNESCAN litigation

US Patents and Regulatory Information for TECHNESCAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Mallinckrodt TECHNESCAN MAA technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017842-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Draximage TECHNESCAN GLUCEPTATE technetium tc-99m gluceptate kit INJECTABLE;INJECTION 018272-001 Jan 27, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Draximage TECHNESCAN HIDA technetium tc-99m lidofenin kit INJECTABLE;INJECTION 018489-001 Oct 31, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Curium TECHNESCAN PYP KIT technetium tc-99m pyrophosphate kit INJECTABLE;INJECTION 017538-001 Approved Prior to Jan 1, 1982 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TECHNESCAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Harvard Business School
Mallinckrodt
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.